InnovAge director granted 8,539 RSUs

TAVENNER MARILYN B reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 07/02/2026 - 04:33 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

TAVENNER MARILYN B reported acquisition or exercise transactions in this Form 4 filing.

InnovAge Holding Corp. director Marilyn B. Tavenner received an equity award in the form of 8,539 Restricted Stock Units, which cost her nothing per unit. These RSUs will settle in common shares and vest in full on June 30, 2027, if she continues serving the company. After this grant, she directly holds 53,696 shares.

Insider Trade Summary

Grant/Award: 8,539 shares

Grant/Award 1 txn

Insider TAVENNER MARILYN B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.001 par value	8,539	$0.00	$0.00

Holdings After Transaction: Common Stock, $0.001 par value — 53,696 shares (Direct)

Holdings Before and After: Common Stock, $0.001 par value, 45,157 to 53,696 shares (Direct)

Footnotes (1)

1. F1. Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer.

Key Figures

RSUs granted: 8,539 units Grant price: $0.00 per unit Shares after grant: 53,696 shares +1 more

4 metrics

RSUs granted 8,539 units Equity award to director Marilyn B. Tavenner

Grant price $0.00 per unit Restricted Stock Unit award cost to recipient

Shares after grant 53,696 shares Director’s direct InnovAge holdings following transaction

Vesting date June 30, 2027 RSUs vest in full on this date if service continues

Key Terms

Restricted Stock Units ("RSUs"), vest in full, continued service

3 terms

Restricted Stock Units ("RSUs") financial

"Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vest in full financial

"and will vest in full on June 30, 2027, subject to the Reporting Person's continued service"

continued service financial

"will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did InnovAge (INNV) director Marilyn Tavenner receive in this Form 4 filing?

Marilyn B. Tavenner received an equity award of 8,539 Restricted Stock Units from InnovAge Holding Corp. These RSUs convert into common shares at no cost to her, providing stock-based compensation instead of a cash salary increase.

At what cost were the InnovAge (INNV) RSUs granted to the director?

The 8,539 Restricted Stock Units were granted at a price of $0.00 per unit. This indicates they are compensation awards, not open‑market purchases, aligning the director’s interests with shareholders through additional stock exposure.

When will Marilyn Tavenner’s InnovAge (INNV) RSUs vest?

The Restricted Stock Units will vest in full on June 30, 2027. Vesting is contingent on Marilyn B. Tavenner’s continued service with InnovAge, encouraging long‑term board involvement and alignment with the company’s multi‑year performance.

How many InnovAge (INNV) shares does the director hold after this transaction?

Following the RSU grant, Marilyn B. Tavenner directly holds 53,696 InnovAge common shares. This total includes the newly awarded units, increasing her overall equity stake and further linking her personal financial outcomes to company performance.

Is the InnovAge (INNV) Form 4 transaction a market buy or sell?

The transaction is a grant of 8,539 Restricted Stock Units, not a market buy or sell. It represents stock-based compensation awarded by the company, so it does not reflect an open-market trading decision by the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TAVENNER MARILYN B

(Last) (First) (Middle)

8950 E LOWRY BLVD

(Street)

DENVER COLORADO 80230

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
InnovAge Holding Corp. [ INNV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.001 par value	07/01/2026		A		8,539(1)	A	$0	53,696	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents Restricted Stock Units ("RSUs") which will be settled in shares of common stock of the Issuer and will vest in full on June 30, 2027, subject to the Reporting Person's continued service with the Issuer.

Remarks:

	/s/ Nicole D'Amato, by Power of Attorney	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)